Quantum-Si incorporated (NASDAQ:QSI) Shares Sold by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. decreased its holdings in shares of Quantum-Si incorporated (NASDAQ:QSI) by 10.8% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 232,360 shares of the company’s stock after selling 28,082 shares during the period. Charles Schwab Investment Management Inc. owned approximately 0.16% of Quantum-Si worth $205,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the business. SG Americas Securities LLC acquired a new stake in shares of Quantum-Si during the 3rd quarter valued at approximately $53,000. Green Alpha Advisors LLC increased its stake in Quantum-Si by 35.4% in the 3rd quarter. Green Alpha Advisors LLC now owns 175,055 shares of the company’s stock valued at $154,000 after purchasing an additional 45,796 shares in the last quarter. XTX Topco Ltd acquired a new position in Quantum-Si during the second quarter worth $25,000. Finally, Bank of New York Mellon Corp boosted its position in Quantum-Si by 3.5% during the second quarter. Bank of New York Mellon Corp now owns 322,460 shares of the company’s stock worth $339,000 after purchasing an additional 10,811 shares in the last quarter. 39.90% of the stock is owned by hedge funds and other institutional investors.

Quantum-Si Stock Performance

QSI stock opened at $1.29 on Friday. The stock’s 50 day moving average price is $1.08 and its 200 day moving average price is $1.05. The firm has a market cap of $184.10 million, a P/E ratio of -2.02 and a beta of 3.20. Quantum-Si incorporated has a 1 year low of $0.61 and a 1 year high of $2.58.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on the company. HC Wainwright raised their price target on Quantum-Si from $4.00 to $5.50 and gave the company a “buy” rating in a research report on Thursday, November 21st. Canaccord Genuity Group dropped their target price on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a report on Wednesday, November 13th.

About Quantum-Si

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.